Arcstone securities and investments corp. publishes industry report on the rapid expansion of the oral stimulant pouch market

New york, new york, dallas, texas, and toronto, ontario--(newsfile corp. - april 28, 2025) - arcstone securities and investments corp. ("arcstone"), a leading cross-border financial services firm, today announced the publication of an industry report on the rapidly emerging oral stimulant pouch market — a multi-billion dollar, high-growth vertical within the health and wellness consumer sector. in the report, arcstone highlights mangoceuticals, inc. (nasdaq: mgrx) ("mangoceuticals") following two transformative transactions: acquisition of the north american rights to diabetinol, expanding its health and wellness product pipeline; and acquisition of selective executives, ip, and assets of smokeless technology corp., establishing a leadership position in the oral stimulant pouch market mangoceuticals, inc. is strategically positioned to capitalize on this expansion by leveraging its proprietary science, ip portfolio, and product rights to target large addressable markets including energy, mood enhancement, weight loss, diabetes management, and more.
MGRX Ratings Summary
MGRX Quant Ranking